Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort

Archive ouverte

Pasquier, David | Darlix, Amélie | Louvel, Guillaume | Fraisse, Julien | Jacot, William | Brain, Etienne | Petit, Adeline | Mouret-Reynier, Marie Ange | Gonçalves, Anthony | Dalenc, Florence | Deluche, Elise | Fresnel, Jean Sébastien | Augereau, Paule | Ferrero, Jean Marc | Geffrelot, Julien | Fumet, Jean-David | Lecouillard, Isabelle | Cottu, Paul | Petit, Thierry | Uwer, Lionel | Jouannaud, Christelle | Leheurteur, Marianne | Dieras, Véronique | Robain, Mathieu | Mouttet-Audouard, Raphaelle | Bachelot, Thomas | Courtinard, Coralie

Edité par CCSD ; Elsevier -

International audience. The aims of the present study were to describe treatment patterns and survival outcomes in patients with central nervous system metastases (CNSM) selected among metastatic breast cancer (MBC) patients included in a retrospective study from the Epidemiological Strategy and Medical Economics (ESME) MBC cohort.

Suggestions

Du même auteur

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Archive ouverte | Darlix, Amélie | CCSD

International audience. Abstract Background Metastatic breast cancer (MBC) behaviour differs depending on hormone receptors (HR) and human epidermal growth factor receptor (HER2) statuses. Methods The kinetics of ce...

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Archive ouverte | Deluche, Elise | CCSD

International audience. Real-world data inform the outcome comparisons and help the development of new therapeutic strategies. To this end, we aimed to describe the full characteristics and outcomes in the Epidemiol...

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Archive ouverte | Gobbini, Elisa | CCSD

International audience. Real-life analysis of overall survival (OS) trends among metastatic breast cancer (MBC) patients may help define medical needs and evaluate the impact of public health investments. The presen...

Chargement des enrichissements...